Plasma Epstein-Barr Virus DNA and Risk of Future Nasopharyngeal Cancer.

MLA

Chan, K. C.Allen, et al. “Plasma Epstein-Barr Virus DNA and Risk of Future Nasopharyngeal Cancer.” NEJM Evidence, vol. 2, no. 7, July 2023, p. EVIDoa2200309. EBSCOhost, https://doi.org/10.1056/EVIDoa2200309.

APA

Chan, K. C. A., Lam, W. K. J., King, A., Lin, V. S., Lee, P. P. H., Zee, B. C. Y., Chan, S. L., Tse, I. O. L., Tsang, A. F. C., Li, M. Z. J., Jiang, P., Ai, Q. Y. H., Poon, D. M. C., Au, K. H., Hui, E. P., Ma, B. B. Y., Van Hasselt, A. C., Chan, A. T. C., Woo, J. K. S., & Lo, Y. M. D. (2023). Plasma Epstein-Barr Virus DNA and Risk of Future Nasopharyngeal Cancer. NEJM Evidence, 2(7), EVIDoa2200309. https://doi.org/10.1056/EVIDoa2200309

Chicago

Chan, K C Allen, W K Jacky Lam, Ann King, Vivien S Lin, Patrick P H Lee, Benny C Y Zee, Stephen L Chan, et al. 2023. “Plasma Epstein-Barr Virus DNA and Risk of Future Nasopharyngeal Cancer.” NEJM Evidence 2 (7): EVIDoa2200309. doi:10.1056/EVIDoa2200309.